Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Nuclear Medicine

  Free Subscription

Articles published in Ann Nucl Med

Retrieve available abstracts of 182 articles:
HTML format

Single Articles

    November 2021
  1. KITAMURA Y, Baba S, Isoda T, Maruoka Y, et al
    Usefulness of semi-quantitative analysis in (123)I metaiodobenzylguanidine SPECT/CT for the differentiation of pheochromocytoma and cortical adenoma.
    Ann Nucl Med. 2021 Nov 26. pii: 10.1007/s12149-021-01690.
    PubMed     Abstract available

  2. MA X, Guo L, Zhang H, Han K, et al
    Predictive value of SPECT myocardial perfusion imaging in patients with unrevascularized coronary chronic total occlusion.
    Ann Nucl Med. 2021 Nov 10. pii: 10.1007/s12149-021-01692.
    PubMed     Abstract available

  3. ICHIKAWA H, Miyaji N, Onoguchi M, Shibutani T, et al
    Feasibility of ultra-high-speed acquisition in xSPECT bone algorithm: a phantom study with advanced bone SPECT-specific phantom.
    Ann Nucl Med. 2021 Nov 3. pii: 10.1007/s12149-021-01689.
    PubMed     Abstract available

  4. GUO H, Xu K, Duan G, Wen L, et al
    Progress and future prospective of FDG-PET/CT imaging combined with optimized procedures in lung cancer: toward precision medicine.
    Ann Nucl Med. 2021 Nov 2. pii: 10.1007/s12149-021-01683.
    PubMed     Abstract available

    October 2021
  5. CHEN Y, Wang Z, Yin G, Sui C, et al
    Prediction of HER2 expression in breast cancer by combining PET/CT radiomic analysis and machine learning.
    Ann Nucl Med. 2021 Oct 30. pii: 10.1007/s12149-021-01688.
    PubMed     Abstract available

  6. OZKAN ZG, Has Simsek D, Kuyumcu S, Oflas M, et al
    Prognostic value of FDG PET-CT in suspected recurrence of colorectal carcinoma: survival outcomes of a 10-year follow-up : FDG PET in recurrent colorectal CA.
    Ann Nucl Med. 2021 Oct 14. pii: 10.1007/s12149-021-01684.
    PubMed     Abstract available

  7. KAWAKUBO M, Nagao M, Kikuchi N, Yamamoto A, et al
    (13)N-ammonia positron emission tomography-derived left-ventricular strain in patients after heart transplantation validated using cardiovascular magnetic resonance feature tracking as reference.
    Ann Nucl Med. 2021 Oct 13. pii: 10.1007/s12149-021-01686.
    PubMed     Abstract available

    September 2021
  8. ONWANNA J, Chantadisai M, Tepmongkol S, Fahey F, et al
    Impact of reconstruction parameters on lesion detection and localization in joint ictal/inter-ictal SPECT reconstruction.
    Ann Nucl Med. 2021 Sep 24. pii: 10.1007/s12149-021-01680.
    PubMed     Abstract available

    August 2021
  9. ELBOGA U, Sahin E, Kus T, Cayirli YB, et al
    Superiority of (68)Ga-FAPI PET/CT scan in detecting additional lesions compared to (18)FDG PET/CT scan in breast cancer.
    Ann Nucl Med. 2021 Aug 26. pii: 10.1007/s12149-021-01672.
    PubMed     Abstract available

  10. KOTANI T, Nishimura M, Tamaki N, Matsushima S, et al
    Comparison between dynamic whole-body FDG-PET and early-delayed imaging for the assessment of motion in focal uptake in colorectal area.
    Ann Nucl Med. 2021 Aug 23. pii: 10.1007/s12149-021-01671.
    PubMed     Abstract available

  11. ZHENG S, Lin R, Chen S, Zheng J, et al
    Characterization of the benign lesions with increased (68)Ga-FAPI-04 uptake in PET/CT.
    Ann Nucl Med. 2021 Aug 23. pii: 10.1007/s12149-021-01673.
    PubMed     Abstract available

  12. WAKABAYASHI T, Hirose Y, Miyake K, Arakawa Y, et al
    Determining the extent of tumor resection at surgical planning with (18)F-fluciclovine PET/CT in patients with suspected glioma: multicenter phase III trials.
    Ann Nucl Med. 2021 Aug 18. pii: 10.1007/s12149-021-01670.
    PubMed     Abstract available

  13. UCHIYAMA Y, Hirata K, Watanabe S, Okamoto S, et al
    Development and validation of a prediction model based on the organ-based metabolic tumor volume on FDG-PET in patients with differentiated thyroid carcinoma.
    Ann Nucl Med. 2021 Aug 11. pii: 10.1007/s12149-021-01664.
    PubMed     Abstract available

  14. KITA A, Okazawa H, Sugimoto K, Kaido R, et al
    Acquisition count dependence of the specific binding ratio in (123)I-FP-CIT SPECT.
    Ann Nucl Med. 2021 Aug 10. pii: 10.1007/s12149-021-01668.
    PubMed     Abstract available

  15. ITO K, Kitajima K, Toriihara A, Ishibashi M, et al
    (18)F-FDG PET/CT for monitoring anti-PD-1 therapy in patients with non-small cell lung cancer using SUV harmonization of results obtained with various types of PET/CT scanners used at different centers.
    Ann Nucl Med. 2021 Aug 9. pii: 10.1007/s12149-021-01667.
    PubMed     Abstract available

  16. TOYOHARA J, Sakata M, Ishibashi K, Mossel P, et al
    First clinical assessment of [(18)F]MC225, a novel fluorine-18 labelled PET tracer for measuring functional P-glycoprotein at the blood-brain barrier.
    Ann Nucl Med. 2021 Aug 8. pii: 10.1007/s12149-021-01666.
    PubMed     Abstract available

  17. WATANABE S, Ueno T, Kimura Y, Mishina M, et al
    Generative image transformer (GIT): unsupervised continuous image generative and transformable model for [(123)I]FP-CIT SPECT images.
    Ann Nucl Med. 2021 Aug 4. pii: 10.1007/s12149-021-01661.
    PubMed     Abstract available

    July 2021
  18. BORGHETTI P, Toraci C, Imbrescia J, Volpi G, et al
    The potential role of SPECT/CT in the clinical management of COVID-19 lung cancer patients undergoing radiotherapy.
    Ann Nucl Med. 2021 Jul 28. pii: 10.1007/s12149-021-01662.

  19. JO KH, Kim S, Hwang SH, Jeong YH, et al
    Characteristics of surgically transposed ovaries on (18)F-FDG PET/CT among patients with cancer.
    Ann Nucl Med. 2021 Jul 26. pii: 10.1007/s12149-021-01645.
    PubMed     Abstract available

  20. ACUNA HERNANDEZ M, Sanchez Orduz L, Cancino Ramos U, Vallejo Armenta P, et al
    Is there a consensus between clinical practice guidelines for conventional and molecular nuclear medicine studies in parathyroid pathology?
    Ann Nucl Med. 2021 Jul 24. pii: 10.1007/s12149-021-01658.
    PubMed     Abstract available

  21. SAGARA H, Inoue K, Yaku H, Ohsawa A, et al
    Optimization of injection dose in (18)F-FDG PET/CT based on the 2020 national diagnostic reference levels for nuclear medicine in Japan.
    Ann Nucl Med. 2021 Jul 21. pii: 10.1007/s12149-021-01656.
    PubMed     Abstract available

  22. GALIUTO L, Leccisotti L, Locorotondo G, Porto I, et al
    Coronary plaque instability assessed by positron emission tomography and optical coherence tomography.
    Ann Nucl Med. 2021 Jul 17. pii: 10.1007/s12149-021-01651.
    PubMed     Abstract available

  23. GREGG S, Keramida G, Peters AM
    Measuring myocardial blood flow with (82)rubidium using Gjedde-Patlak-Rutland graphical analysis.
    Ann Nucl Med. 2021;35:777-784.
    PubMed     Abstract available

  24. SEKIKAWA Y, Funada K, Akamatsu G, Himuro K, et al
    Monte Carlo simulation of the acquisition conditions for (177)Lu molecular imaging of hepatic tumors.
    Ann Nucl Med. 2021;35:823-833.
    PubMed     Abstract available

  25. MORLAND D, Zizi G, Godard F, Gauchy AC, et al
    18F-FDG cerebellum/liver index as a prognostic factor for progression-free survival in diffuse large B-cell lymphoma.
    Ann Nucl Med. 2021;35:785-793.
    PubMed     Abstract available

  26. KOBAYASHI Y, Okui T, Tsujimoto M, Ikeda H, et al
    Effect of morphological findings in computed tomography on the quantitative values in single-photon emission computed tomography for patients with antiresorptive agent-related osteonecrosis of the jaw: a cross-sectional study.
    Ann Nucl Med. 2021;35:853-860.
    PubMed     Abstract available

  27. WATABE T, Hosono M, Kinuya S, Yamada T, et al
    Manual on the proper use of sodium astatide ([(211)At]NaAt) injections in clinical trials for targeted alpha therapy (1st edition).
    Ann Nucl Med. 2021;35:753-766.
    PubMed     Abstract available

  28. MA G, Gu B, Hu J, Kong L, et al
    Pretreatment (18)F-FDG uptake heterogeneity can predict treatment outcome of carbon ion radiotherapy in patients with locally recurrent nasopharyngeal carcinoma.
    Ann Nucl Med. 2021;35:834-842.
    PubMed     Abstract available

    June 2021
  29. KUYUMCU S, Isik EG, Tiryaki TO, Has-Simsek D, et al
    Prognostic significance of (68)Ga-Pentixafor PET/CT in multiple myeloma recurrence: a comparison to (18)F-FDG PET/CT and laboratory results.
    Ann Nucl Med. 2021 Jun 29. pii: 10.1007/s12149-021-01652.
    PubMed     Abstract available

  30. FASSBIND S, Ferraro DA, Stelmes JJ, Fankhauser CD, et al
    (68)Ga-PSMA-11 PET imaging in patients with ongoing androgen deprivation therapy for advanced prostate cancer.
    Ann Nucl Med. 2021 Jun 29. pii: 10.1007/s12149-021-01646.
    PubMed     Abstract available

  31. OZTURK BC, Atahan E, Gencer A, Harbiyeli DO, et al
    Investigation of perfusion defects by Q-SPECT/CT in patients with mild-to-moderate course of COVID-19 and low clinical probability for pulmonary embolism.
    Ann Nucl Med. 2021 Jun 25. pii: 10.1007/s12149-021-01647.
    PubMed     Abstract available

  32. KARLS S, Gold R, Kravets S, Wang Y, et al
    Correlation of 68Ga-DOTATATE uptake on PET/CT with pathologic features of cellular proliferation in neuroendocrine neoplasms.
    Ann Nucl Med. 2021 Jun 19. pii: 10.1007/s12149-021-01642.
    PubMed     Abstract available

  33. KAUSHIK P, Patel C, Gulati GS, Seth S, et al
    Comparison of (68)Ga-DOTANOC PET/CT with cardiac MRI in patients with clinical suspicion of cardiac sarcoidosis.
    Ann Nucl Med. 2021 Jun 14. pii: 10.1007/s12149-021-01641.
    PubMed     Abstract available

  34. LEE SW, Jeong SY, Kim K, Kim SJ, et al
    Direct comparison of F-18 FDG PET/CT and MRI to predict pathologic response to neoadjuvant treatment in locally advanced rectal cancer: a meta-analysis.
    Ann Nucl Med. 2021 Jun 10. pii: 10.1007/s12149-021-01639.
    PubMed     Abstract available

  35. KARAHAN SEN NP, Aksu A, Capa Kaya G
    A different overview of staging PET/CT images in patients with esophageal cancer: the role of textural analysis with machine learning methods.
    Ann Nucl Med. 2021 Jun 9. pii: 10.1007/s12149-021-01638.
    PubMed     Abstract available

  36. IKOMA Y, Takuwa H, Nishino A, Maeda J, et al
    Measurement of changes in endogenous serotonin level by positron emission tomography with [(18)F]altanserin.
    Ann Nucl Med. 2021 Jun 8. pii: 10.1007/s12149-021-01633.
    PubMed     Abstract available

  37. LI Y, Li Y, Huang Y, Wu X, et al
    Usefulness of (18)F-FDG PET/CT in treatment-naive patients with thymic squamous cell carcinoma.
    Ann Nucl Med. 2021 Jun 8. pii: 10.1007/s12149-021-01640.
    PubMed     Abstract available

  38. LUO R, Wang L, Ye F, Wang YR, et al
    [(18)F]FEDAC translocator protein positron emission tomography-computed tomography for early detection of mitochondrial dysfunction secondary to myocardial ischemia.
    Ann Nucl Med. 2021 Jun 3. pii: 10.1007/s12149-021-01630.
    PubMed     Abstract available

  39. NI YC, Tseng FP, Pai MC, Hsiao IT, et al
    Detection of Alzheimer's disease using ECD SPECT images by transfer learning from FDG PET.
    Ann Nucl Med. 2021 Jun 2. pii: 10.1007/s12149-021-01626.
    PubMed     Abstract available

  40. FUKUNAGA T, Sanui K, Kadokami T, Sasaki M, et al
    Influences of radionuclides on left ventricular phase analysis of gated myocardial perfusion single-photon emission computed tomography images in ischemic heart disease.
    Ann Nucl Med. 2021;35:735-743.
    PubMed     Abstract available

  41. QIU ZL, Saito S, Kayano D, Wakabayashi H, et al
    Comparison of the detecting capability between (123)I-mIBG and post-therapeutic (131)I-mIBG scintigraphy for curie scoring in patients with neuroblastoma after chemotherapy.
    Ann Nucl Med. 2021;35:649-661.
    PubMed     Abstract available

  42. KAPADIA A, Desai P, Dmytriw A, Maralani P, et al
    In vivo detection of beta-amyloid at the nasal cavity and other skull-base sites: a retrospective evaluation of ADNI1/GO.
    Ann Nucl Med. 2021;35:728-734.
    PubMed     Abstract available

    May 2021
  43. EVANGELISTA L, Zucchetta P, Moletta L, Serafini S, et al
    The role of FDG PET/CT or PET/MRI in assessing response to neoadjuvant therapy for patients with borderline or resectable pancreatic cancer: a systematic literature review.
    Ann Nucl Med. 2021 May 28. pii: 10.1007/s12149-021-01629.
    PubMed     Abstract available

  44. OTANI T, Otsuka H, Matsushita K, Otomi Y, et al
    Effect of different examination conditions on image quality and quantitative value of amyloid positron emission tomography using (18)F-flutemetamol.
    Ann Nucl Med. 2021 May 27. pii: 10.1007/s12149-021-01634.
    PubMed     Abstract available

  45. ICHIKAWA H, Kawakami K, Onoguchi M, Shibutani T, et al
    Automatic quantification package (Hone Graph) for phantom-based image quality assessment in bone SPECT: computerized automatic classification of detectability.
    Ann Nucl Med. 2021 May 24. pii: 10.1007/s12149-021-01631.
    PubMed     Abstract available

  46. TERESINSKA A, Wozniak O, Maciag A, Wnuk J, et al
    Quality and utility of [(123)I]I-metaiodobenzylguanidine cardiac SPECT imaging in nondiabetic postinfarction heart failure patients qualified for implantable cardioverter defibrillator.
    Ann Nucl Med. 2021 May 23. pii: 10.1007/s12149-021-01628.
    PubMed     Abstract available

  47. HUNG GU, Zou J, He Z, Zhang X, et al
    Left-ventricular dyssynchrony in viable myocardium by myocardial perfusion SPECT is predictive of mechanical response to CRT.
    Ann Nucl Med. 2021 May 21. pii: 10.1007/s12149-021-01632.
    PubMed     Abstract available

  48. KIM M, Gu W, Nakajima T, Higuchi T, et al
    Texture analysis of [(18)F]-fluorodeoxyglucose-positron emission tomography/computed tomography for predicting the treatment response of postoperative recurrent or metastatic oral squamous cell carcinoma treated with cetuximab.
    Ann Nucl Med. 2021 May 20. pii: 10.1007/s12149-021-01623.
    PubMed     Abstract available

  49. CHIMURA M, Ohtani T, Sera F, Nakamoto K, et al
    Focal severe decrease in myocardial technetium-99 m sestamibi uptake indicates ventricular irreversibility in patients with dilated cardiomyopathy.
    Ann Nucl Med. 2021 May 18. pii: 10.1007/s12149-021-01625.
    PubMed     Abstract available

  50. ASA S, Sonmezoglu K, Uslu-Besli L, Sahin OE, et al
    Evaluation of F-18 DOPA PET/CT in the detection of recurrent or metastatic medullary thyroid carcinoma: comparison with GA-68 DOTA-TATE PET/CT.
    Ann Nucl Med. 2021 May 15. pii: 10.1007/s12149-021-01627.
    PubMed     Abstract available

  51. HOTTA M, Minamimoto R, Gohda Y, Miwa K, et al
    Prognostic value of (18)F-FDG PET/CT with texture analysis in patients with rectal cancer treated by surgery.
    Ann Nucl Med. 2021 May 4. pii: 10.1007/s12149-021-01622.
    PubMed     Abstract available

  52. KOMEK H, Can C, Guzel Y, Oruc Z, et al
    (68)Ga-FAPI-04 PET/CT, a new step in breast cancer imaging: a comparative pilot study with the (18)F-FDG PET/CT.
    Ann Nucl Med. 2021 May 2. pii: 10.1007/s12149-021-01616.
    PubMed     Abstract available

  53. LEE CH, Lim I, Woo SK, Kim W, et al
    Targeted alpha immunotherapy of CD20-positive B-cell lymphoma model: dosimetry estimate of (225)Ac-DOTA-rituximab using (64)Cu-DOTA-rituximab.
    Ann Nucl Med. 2021;35:639-647.
    PubMed     Abstract available

  54. JUWEID ME, Alhouri A, Baniissa B, Rimawi D, et al
    Transient ischemic dilatation with adenosine (99m)Tc-sestamibi stress: prognostic significance in patients with normal myocardial perfusion.
    Ann Nucl Med. 2021;35:569-579.
    PubMed     Abstract available

  55. HUANG HL, Ngam PI, Tan KM, Ng DCE, et al
    The exact Deauville score, NABS score and high SUVmax predicts outcome in extranodal natural killer/T-cell lymphoma.
    Ann Nucl Med. 2021;35:557-568.
    PubMed     Abstract available

  56. TUNCEL M, Telli T, Tuncali MC, Karabulut E, et al
    Predictive factors of tumor sink effect: Insights from (177)Lu-Prostate-specific membrane antigen therapy.
    Ann Nucl Med. 2021;35:529-539.
    PubMed     Abstract available

    April 2021
  57. KURISU S, Nitta K, Watanabe N, Ikenaga H, et al
    Associations of frontal QRS-T angle with left ventricular volume and function derived from ECG-gated SPECT in patients with advanced chronic kidney disease.
    Ann Nucl Med. 2021 Apr 18. pii: 10.1007/s12149-021-01596.
    PubMed     Abstract available

  58. HOU Y, Guo K, Fan X, Shang K, et al
    Crossed cerebellar diaschisis: risk factors and prognostic value in focal cortical dysplasia by (18)F-FDG PET/CT.
    Ann Nucl Med. 2021 Apr 11. pii: 10.1007/s12149-021-01613.
    PubMed     Abstract available

  59. HASHIMOTO F, Ito M, Ote K, Isobe T, et al
    Deep learning-based attenuation correction for brain PET with various radiotracers.
    Ann Nucl Med. 2021 Apr 3. pii: 10.1007/s12149-021-01611.
    PubMed     Abstract available

  60. CHOI YJ, Jo K, Hwang SH, Jeong Y, et al
    Association between PD-L1 expression and (18)F-FDG uptake in ovarian cancer.
    Ann Nucl Med. 2021;35:415-420.
    PubMed     Abstract available

  61. BANDO R, Otsuka H, Otani T, Matsuda N, et al
    A new quantitative index in the diagnosis of Parkinson syndrome by dopamine transporter single-photon emission computed tomography.
    Ann Nucl Med. 2021;35:504-513.
    PubMed     Abstract available

  62. RADNIA A, Abdollahzadeh H, Teimourian B, Farahani MH, et al
    Development and characterization of an all-in-one gamma probe with auto-peak detection for sentinel lymph node biopsy based on NEMA NU3-2004 standard.
    Ann Nucl Med. 2021;35:438-446.
    PubMed     Abstract available

    March 2021
  63. SATOH Y, Imai M, Hirata K, Asakawa Y, et al
    Optimal relaxation parameters of dynamic row-action maximum likelihood algorithm and post-smoothing filter for image reconstruction of dedicated breast PET.
    Ann Nucl Med. 2021 Mar 27. pii: 10.1007/s12149-021-01604.
    PubMed     Abstract available

  64. ZIMMERMANN PA, Houdu B, Cesaire L, Nakouri I, et al
    Revisiting detection of in-transit metastases in melanoma patients using digital (18)F-FDG PET/CT with small-voxel reconstruction.
    Ann Nucl Med. 2021 Mar 26. pii: 10.1007/s12149-021-01608.
    PubMed     Abstract available

  65. SCOBIOALA S, Kittel C, Wolters H, Huss S, et al
    Diagnostic efficiency of hybrid imaging using PSMA ligands, PET/CT, PET/MRI and MRI in identifying malignant prostate lesions.
    Ann Nucl Med. 2021 Mar 19. pii: 10.1007/s12149-021-01606.
    PubMed     Abstract available

  66. HE J, Wang Q, Zhang Y, Wu H, et al
    Preoperative prediction of regional lymph node metastasis of colorectal cancer based on (18)F-FDG PET/CT and machine learning.
    Ann Nucl Med. 2021 Mar 18. pii: 10.1007/s12149-021-01605.
    PubMed     Abstract available

  67. MA G, Liu C, Lian W, Zhang Y, et al
    (18)F-FLT PET/CT imaging for early monitoring response to CDK4/6 inhibitor therapy in triple negative breast cancer.
    Ann Nucl Med. 2021 Mar 10. pii: 10.1007/s12149-021-01603.
    PubMed     Abstract available

  68. SAKAGUCHI K, Kaida H, Yoshida S, Ishii K, et al
    Attenuation correction using deep learning for brain perfusion SPECT images.
    Ann Nucl Med. 2021 Mar 9. pii: 10.1007/s12149-021-01600.
    PubMed     Abstract available

  69. WATABE T, Uemura M, Soeda F, Naka S, et al
    High detection rate in [(18)F]PSMA-1007 PET: interim results focusing on biochemical recurrence in prostate cancer patients.
    Ann Nucl Med. 2021 Mar 4. pii: 10.1007/s12149-021-01602.
    PubMed     Abstract available

  70. KAWANO M, Tsuchiya J, Bae H, Kimura K, et al
    Phase I clinical study of NMB58, a novel positron emission tomography (PET)-myocardial perfusion imaging tracer, conducted to evaluate its safety and pharmacokinetics in Japanese healthy adult males.
    Ann Nucl Med. 2021 Mar 1. pii: 10.1007/s12149-021-01601.
    PubMed     Abstract available

  71. SHAO F, Zhao X, Toyama H, Ichihara T, et al
    Semi-quantitative assessment optimized the grading of pulmonary aspiration on salivagram in children.
    Ann Nucl Med. 2021;35:321-327.
    PubMed     Abstract available

  72. DOTINGA M, van Dijk JD, Vendel BN, Slump CH, et al
    Clinical value of machine learning-based interpretation of I-123 FP-CIT scans to detect Parkinson's disease: a two-center study.
    Ann Nucl Med. 2021;35:378-385.
    PubMed     Abstract available

    February 2021
  73. KITAMURA Y, Baba S, Isoda T, Maruoka Y, et al
    (123)I metaiodobenzylguanidine (MIBG) uptake predicts early relapse of neuroblastoma using semi-quantitative SPECT/CT analysis.
    Ann Nucl Med. 2021 Feb 14. pii: 10.1007/s12149-021-01595.
    PubMed     Abstract available

  74. YILDIRIM OA, Gundogan C, Can C, Poyraz K, et al
    Correlations between whole body volumetric parameters of (68)Ga-PSMA PET/CT and biochemical-histopathological parameters in castration-naive and resistant prostate cancer patients.
    Ann Nucl Med. 2021 Feb 14. pii: 10.1007/s12149-021-01594.
    PubMed     Abstract available

  75. KATO A, Nakamoto Y, Ishimori T, Hayakawa N, et al
    Diagnostic performance of (68)Ga-DOTATOC PET/CT in tumor-induced osteomalacia.
    Ann Nucl Med. 2021 Feb 13. pii: 10.1007/s12149-021-01575.
    PubMed     Abstract available

  76. PACE L, Nicolai E, Cavaliere C, Basso L, et al
    Prognostic value of 18F-FDG PET/MRI in patients with advanced oropharyngeal and hypopharyngeal squamous cell carcinoma.
    Ann Nucl Med. 2021 Feb 11. pii: 10.1007/s12149-021-01590.
    PubMed     Abstract available

  77. YOON H, Ha S, Kwon SJ, Park SY, et al
    Prognostic value of tumor metabolic imaging phenotype by FDG PET radiomics in HNSCC.
    Ann Nucl Med. 2021 Feb 8. pii: 10.1007/s12149-021-01586.
    PubMed     Abstract available

  78. ALBERTS I, Sachpekidis C, Prenosil G, Viscione M, et al
    Digital PET/CT allows for shorter acquisition protocols or reduced radiopharmaceutical dose in [(18)F]-FDG PET/CT.
    Ann Nucl Med. 2021 Feb 7. pii: 10.1007/s12149-021-01588.
    PubMed     Abstract available

  79. JAMSEK J, Hocevar M, Bergant D, Zaletel K, et al
    Diagnostic value of [(18)F]Fluorocholine PET/CT in detection of primary medullary thyroid cancer.
    Ann Nucl Med. 2021 Feb 5. pii: 10.1007/s12149-021-01579.
    PubMed     Abstract available

  80. PENG L, Hong X, Yuan Q, Lu L, et al
    Prediction of local recurrence and distant metastasis using radiomics analysis of pretreatment nasopharyngeal [18F]FDG PET/CT images.
    Ann Nucl Med. 2021 Feb 4. pii: 10.1007/s12149-021-01585.
    PubMed     Abstract available

  81. KONG Z, Zhang Y, Liu D, Liu P, et al
    Role of traditional CHO PET parameters in distinguishing IDH, TERT and MGMT alterations in primary diffuse gliomas.
    Ann Nucl Med. 2021 Feb 2. pii: 10.1007/s12149-021-01589.
    PubMed     Abstract available

  82. SAKATANI T, Nakajima K, Fujita H, Nishimura T, et al
    Cardiovascular event risk estimated after coronary revascularization and optimal medical therapy: J-ACCESS4 prognostic study.
    Ann Nucl Med. 2021;35:241-252.
    PubMed     Abstract available

  83. KANG JY, Lee MY, Kim YH
    Associations of physiologic myocardial (18)F-FDG uptake with fasting duration, HbA1c, and regular exercise.
    Ann Nucl Med. 2021;35:195-202.
    PubMed     Abstract available

  84. KONISHI K, Ishiba R, Ikenohira T, Asao T, et al
    The relationship between the quantitative evaluation of thyroid bed uptake and the disappearance of accumulation in adjuvant radioactive iodine therapy for differentiated thyroid cancer.
    Ann Nucl Med. 2021;35:159-166.
    PubMed     Abstract available

    January 2021
  85. CRIMI F, Valeggia S, Baffoni L, Stramare R, et al
    [18F]FDG PET/MRI in rectal cancer.
    Ann Nucl Med. 2021 Jan 31. pii: 10.1007/s12149-021-01580.
    PubMed     Abstract available

  86. ITO H, Kubo H, Takahashi K, Nishijima KI, et al
    Integrated PET/MRI scanner with oxygen-15 labeled gases for quantification of cerebral blood flow, cerebral blood volume, cerebral oxygen extraction fraction and cerebral metabolic rate of oxygen.
    Ann Nucl Med. 2021 Jan 27. pii: 10.1007/s12149-021-01578.
    PubMed     Abstract available

  87. SATOH Y, Kawamoto M, Kubota K, Murakami K, et al
    Clinical practice guidelines for high-resolution breast PET, 2019 edition.
    Ann Nucl Med. 2021 Jan 25. pii: 10.1007/s12149-021-01582.
    PubMed     Abstract available

  88. MACCORA D, Caldarella C, Calcagni ML
    (11)C-Methionine PET/CT in patients with primary hyperparathyroidism and inconclusive pre-operative imaging work-up: diagnostic accuracy and role of semi-quantitative analysis.
    Ann Nucl Med. 2021 Jan 24. pii: 10.1007/s12149-021-01584.
    PubMed     Abstract available

  89. HAN S, Kim YI, Woo S, Kim TH, et al
    Prognostic and predictive values of interim (18)F-FDG PET during neoadjuvant chemoradiotherapy for esophageal cancer: a systematic review and meta-analysis.
    Ann Nucl Med. 2021 Jan 20. pii: 10.1007/s12149-021-01583.
    PubMed     Abstract available

  90. LIU J, Yang X, Yang J
    Prognosis predicting value of semiquantitative parameters of visceral adipose tissue and subcutaneous adipose tissue of (18)F-FDG PET/CT in newly diagnosed secondary hemophagocytic lymphohistiocytosis.
    Ann Nucl Med. 2021 Jan 19. pii: 10.1007/s12149-021-01577.
    PubMed     Abstract available

  91. ZHANG W, Xu S, Yu H, Li X, et al
    Radioactive synthesis of tau PET imaging agent (18)F-AV-1451 and its role in monitoring the progression of Alzheimer's disease and supporting differential diagnosis.
    Ann Nucl Med. 2021 Jan 18. pii: 10.1007/s12149-020-01566.
    PubMed     Abstract available

  92. KONISHI T, Shibutani T, Okuda K, Yoneyama H, et al
    Metal artifact reduction for improving quantitative SPECT/CT imaging.
    Ann Nucl Med. 2021 Jan 18. pii: 10.1007/s12149-020-01560.
    PubMed     Abstract available

  93. CRIMI F, Borsetto D, Stramare R, Di Carlo R, et al
    [(18)F]FDG PET/MRI versus contrast-enhanced MRI in detecting regional HNSCC metastases.
    Ann Nucl Med. 2021 Jan 17. pii: 10.1007/s12149-020-01565.
    PubMed     Abstract available

  94. KANG SY, Moon BS, Kim HO, Yoon HJ, et al
    The impact of data-driven respiratory gating in clinical F-18 FDG PET/CT: comparison of free breathing and deep-expiration breath-hold CT protocol.
    Ann Nucl Med. 2021 Jan 15. pii: 10.1007/s12149-020-01574.
    PubMed     Abstract available

  95. ZAMORA E, Valdivia AY
    Oncologic significance of unexpected osseous foci on FDG-PET without correlative CT abnormalities.
    Ann Nucl Med. 2021 Jan 13. pii: 10.1007/s12149-020-01572.
    PubMed     Abstract available

  96. SHIMIZU Y, Nakai Y, Iikuni S, Watanabe H, et al
    Synthesis and evaluation of gallium-68-labeled nitroimidazole-based imaging probes for PET diagnosis of tumor hypoxia.
    Ann Nucl Med. 2021 Jan 9. pii: 10.1007/s12149-020-01573.
    PubMed     Abstract available

  97. SHIGENO T, Kozaka T, Kitamura Y, Ogawa K, et al
    In vitro and in vivo evaluation of [(125/123)I]-2-[4-(2-iodophenyl)piperidino]cyclopentanol([(125/123)I]-OI5V) as a potential sigma-1 receptor ligand for SPECT.
    Ann Nucl Med. 2021 Jan 8. pii: 10.1007/s12149-020-01552.
    PubMed     Abstract available

  98. HAS SIMSEK D, Isik EG, Engin MN, Kuyumcu S, et al
    Somatostatin receptor-positive breast lesions on (68)Ga-DOTATATE PET/CT.
    Ann Nucl Med. 2021 Jan 5. pii: 10.1007/s12149-020-01570.
    PubMed     Abstract available

  99. YAMANE T, Fukushima K, Shirotake S, Nishimoto K, et al
    Test-retest repeatability of quantitative bone SPECT/CT.
    Ann Nucl Med. 2021 Jan 5. pii: 10.1007/s12149-020-01568.
    PubMed     Abstract available

  100. BRESSER PL, Vorster M, Sathekge MM
    An overview of the developments and potential applications of (68)Ga-labelled PET/CT hypoxia imaging.
    Ann Nucl Med. 2021 Jan 5. pii: 10.1007/s12149-020-01563.
    PubMed     Abstract available

  101. OHBA M, Kobayashi R, Kirii K, Fujita K, et al
    Comparison of Alzheimer's disease patients and healthy controls in the easy Z-score imaging system with differential image reconstruction methods using SPECT/CT: verification using normal database of our institution.
    Ann Nucl Med. 2021 Jan 4. pii: 10.1007/s12149-020-01562.
    PubMed     Abstract available

  102. CHENG JL, Hsu CC, Wang PW, Sung KC, et al
    The feasibility of anterior 180 degrees (99m) Tc-sestamibi parathyroid SPECT/CT.
    Ann Nucl Med. 2021 Jan 3. pii: 10.1007/s12149-020-01553.
    PubMed     Abstract available

  103. MORI H, Taki J, Wakabayashi H, Hiromasa T, et al
    Colchicine treatment early after infarction attenuates myocardial inflammatory response demonstrated by (14)C-methionine imaging and subsequent ventricular remodeling by quantitative gated SPECT.
    Ann Nucl Med. 2021 Jan 3. pii: 10.1007/s12149-020-01559.
    PubMed     Abstract available

  104. NISHII R, Saga T, Sudo H, Togawa T, et al
    Clinical value of PET/CT with carbon-11 4DST in the evaluation of malignant and benign lung tumors.
    Ann Nucl Med. 2021 Jan 2. pii: 10.1007/s12149-020-01554.
    PubMed     Abstract available

  105. SON HJ, Oh JS, Oh M, Lee SJ, et al
    Test-retest reproducibility of dopamine transporter density measured with [(18)F]FP-CIT PET in patients with essential tremor and Parkinson's disease.
    Ann Nucl Med. 2021 Jan 2. pii: 10.1007/s12149-020-01561.
    PubMed     Abstract available

  106. PARGHANE RV, Talole S, Basu S
    (131)I-MIBG negative progressive symptomatic metastatic paraganglioma: response and outcome with (177)Lu-DOTATATE peptide receptor radionuclide therapy.
    Ann Nucl Med. 2021;35:92-101.
    PubMed     Abstract available

  107. SHIN S, Nam HY, Lee MJ, Pak K, et al
    Effect of sex on aging-related decline of dopamine transporter in healthy subjects.
    Ann Nucl Med. 2021;35:76-82.
    PubMed     Abstract available

    November 2020
  108. ARABI H, Zaidi H
    Non-local mean denoising using multiple PET reconstructions.
    Ann Nucl Med. 2020 Nov 26. pii: 10.1007/s12149-020-01550.
    PubMed     Abstract available

  109. ATTARWALA AA, Hardiansyah D, Romano C, Jimenez-Franco LD, et al
    Performance assessment of the ALBIRA II pre-clinical SPECT S102 system for (99m)Tc imaging.
    Ann Nucl Med. 2020 Nov 12. pii: 10.1007/s12149-020-01547.
    PubMed     Abstract available

  110. INUBUSHI M, Miura H, Kuji I, Ito K, et al
    Current status of radioligand therapy and positron-emission tomography with prostate-specific membrane antigen.
    Ann Nucl Med. 2020 Nov 11. pii: 10.1007/s12149-020-01549.
    PubMed     Abstract available

  111. DERLIN T, Schultze-Florey C, Werner RA, Mohn N, et al
    (18)F-FDG PET/CT of off-target lymphoid organs in CD19-targeting chimeric antigen receptor T-cell therapy for relapsed or refractory diffuse large B-cell lymphoma.
    Ann Nucl Med. 2020 Nov 11. pii: 10.1007/s12149-020-01544.
    PubMed     Abstract available

  112. SAID MA, Musarudin M, Zulkaffli NF
    The quantification of PET-CT radiotracers to determine minimal scan time using quadratic formulation.
    Ann Nucl Med. 2020 Nov 3. pii: 10.1007/s12149-020-01543.
    PubMed     Abstract available

    October 2020
  113. ANNUNZIATA S, Pelliccioni A, Hohaus S, Maiolo E, et al
    The prognostic role of end-of-treatment FDG-PET/CT in diffuse large B cell lymphoma: a pilot study application of neural networks to predict time-to-event.
    Ann Nucl Med. 2020 Oct 22. pii: 10.1007/s12149-020-01542.
    PubMed     Abstract available

  114. SEBAN RD, Assie JB, Giroux-Leprieur E, Massiani MA, et al
    FDG-PET biomarkers associated with long-term benefit from first-line immunotherapy in patients with advanced non-small cell lung cancer.
    Ann Nucl Med. 2020 Oct 18. pii: 10.1007/s12149-020-01539.
    PubMed     Abstract available

  115. HANAFY OS, Khalil MM, Khater IM, Mohammed HS, et al
    Development of a new Python-based cardiac phantom for myocardial SPECT imaging.
    Ann Nucl Med. 2020 Oct 17. pii: 10.1007/s12149-020-01534.
    PubMed     Abstract available

  116. JIANG C, Teng Y, Chen J, Wang Z, et al
    Value of (18)F-FDG PET/CT for prognostic stratification in patients with primary intestinal diffuse large B cell lymphoma treated with an R-CHOP-like regimen.
    Ann Nucl Med. 2020 Oct 15. pii: 10.1007/s12149-020-01536.
    PubMed     Abstract available

  117. CHAKRAVARTY R, Shetty P, Nair KVV, Rajeswari A, et al
    Reactor produced [(64)Cu]CuCl2 as a PET radiopharmaceutical for cancer imaging: from radiochemistry laboratory to nuclear medicine clinic.
    Ann Nucl Med. 2020 Oct 13. pii: 10.1007/s12149-020-01522.
    PubMed     Abstract available

  118. HAN S, Oh JS, Kim JS
    Immune microenvironment of the gene signature reflecting the standardised uptake value on (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in head and neck squamous cell carcinoma.
    Ann Nucl Med. 2020 Oct 12. pii: 10.1007/s12149-020-01537.
    PubMed     Abstract available

  119. KANNO M, Tsujikawa T, Narita N, Ito Y, et al
    Comparison of diagnostic accuracy between [(18)F]FDG PET/MRI and contrast-enhanced MRI in T staging for oral tongue cancer.
    Ann Nucl Med. 2020 Oct 10. pii: 10.1007/s12149-020-01526.
    PubMed     Abstract available

  120. KUBOTA K, Tanaka N, Miyata Y, Ohtsu H, et al
    Comparison of (18)F-FDG PET/CT and (67)Ga-SPECT for the diagnosis of fever of unknown origin: a multicenter prospective study in Japan.
    Ann Nucl Med. 2020 Oct 9. pii: 10.1007/s12149-020-01533.
    PubMed     Abstract available

  121. ZHAO P, Yu T, Pan Z
    Prognostic value of the baseline 18F-FDG PET/CT metabolic tumour volume (MTV) and further stratification in low-intermediate (L-I) and high-intermediate (H-I) risk NCCNIPI subgroup by MTV in DLBCL MTV predict prognosis in DLBCL.
    Ann Nucl Med. 2020 Oct 1. pii: 10.1007/s12149-020-01531.
    PubMed     Abstract available

    September 2020
  122. NOMURA M, Toyama H, Suzuki H, Yamada T, et al
    Peripheral benzodiazepine receptor/18 kDa translocator protein positron emission tomography imaging in a rat model of acute brain injury.
    Ann Nucl Med. 2020 Sep 28. pii: 10.1007/s12149-020-01530.
    PubMed     Abstract available

  123. KURISU S, Nitta K, Watanabe N, Ikenaga H, et al
    Effects of upright T-wave in lead aVR on left ventricular volume and function derived from ECG-gated SPECT in patients with advanced chronic kidney disease.
    Ann Nucl Med. 2020 Sep 27. pii: 10.1007/s12149-020-01528.
    PubMed     Abstract available

  124. KANGASMAA T, Hippelainen E, Constable C, Turunen S, et al
    Quantitative Monte Carlo-based brain dopamine transporter SPECT imaging.
    Ann Nucl Med. 2020 Sep 25. pii: 10.1007/s12149-020-01532.
    PubMed     Abstract available

  125. CAGLAR M, Tuncel M, Yildiz E, Karabulut E, et al
    Bone scintigraphy as a gatekeeper for the detection of bone metastases in patients with prostate cancer: comparison with Ga-68 PSMA PET/CT.
    Ann Nucl Med. 2020 Sep 25. pii: 10.1007/s12149-020-01529.
    PubMed     Abstract available

  126. KIM HO, Kim BS, Kang SY, Bang JI, et al
    Metabolic changes in breast cancer on dual-time-point (18)F-FDG PET/CT imaging according to primary tumor uptake and background parenchymal enhancement.
    Ann Nucl Med. 2020 Sep 24. pii: 10.1007/s12149-020-01525.
    PubMed     Abstract available

  127. AOKI Y, Nakayama M, Nomura K, Tomita Y, et al
    The utility of a deep learning-based algorithm for bone scintigraphy in patient with prostate cancer.
    Ann Nucl Med. 2020 Sep 21. pii: 10.1007/s12149-020-01524.
    PubMed     Abstract available

  128. SENDA M
    Standardization of PET imaging and site qualification program by JSNM: collaboration with EANM/EARL.
    Ann Nucl Med. 2020 Sep 16. pii: 10.1007/s12149-020-01518.

  129. PRIETO PRIETO JC, Vallejo Casas JA, Hatzimichael E, Fotopoulos A, et al
    The contribution of metabolic parameters of FDG PET/CT prior and during therapy of adult patients with lymphomas.
    Ann Nucl Med. 2020 Sep 13. pii: 10.1007/s12149-020-01521.
    PubMed     Abstract available

  130. ISHII S, Sugawara S, Yaginuma Y, Kobiyama H, et al
    Causes of false negatives in technetium-99 m methoxyisobutylisonitrile scintigraphy for hyperparathyroidism: influence of size and cysts in parathyroid lesions.
    Ann Nucl Med. 2020 Sep 12. pii: 10.1007/s12149-020-01520.
    PubMed     Abstract available

  131. MANABE O, Naya M, Aikawa T, Tamaki N, et al
    Recent advances in cardiac positron emission tomography for quantitative perfusion analyses and molecular imaging.
    Ann Nucl Med. 2020 Sep 11. pii: 10.1007/s12149-020-01519.
    PubMed     Abstract available

  132. YAMAZAKI K, Nishii R, Maeda T, Makishima H, et al
    Assessment of SPECT-CT fusion images and semi-quantitative evaluation using SUV in (123)I-IMP SPECT in patients with choroidal melanoma.
    Ann Nucl Med. 2020 Sep 9. pii: 10.1007/s12149-020-01517.
    PubMed     Abstract available

    August 2020
  133. ISHII K, Yamada T, Hanaoka K, Kaida H, et al
    Regional gray matter-dedicated SUVR with 3D-MRI detects positive amyloid deposits in equivocal amyloid PET images.
    Ann Nucl Med. 2020 Aug 27. pii: 10.1007/s12149-020-01513.
    PubMed     Abstract available

  134. ABE K, Hosono M, Igarashi T, Iimori T, et al
    The 2020 national diagnostic reference levels for nuclear medicine in Japan.
    Ann Nucl Med. 2020 Aug 27. pii: 10.1007/s12149-020-01512.
    PubMed     Abstract available

  135. PAPANDRIANOS N, Papageorgiou EI, Anagnostis A
    Development of Convolutional Neural Networks to identify bone metastasis for prostate cancer patients in bone scintigraphy.
    Ann Nucl Med. 2020 Aug 24. pii: 10.1007/s12149-020-01510.
    PubMed     Abstract available

  136. NISHIMORI M, Yoshimatsu R, Iwasa H, Miyatake K, et al
    Evaluation of pleural lesions after pleurodesis with OK-432 by fluorodeoxyglucose-positron emission tomography/CT.
    Ann Nucl Med. 2020 Aug 18. pii: 10.1007/s12149-020-01508.
    PubMed     Abstract available

  137. EVANGELISTA L, Ravelli I, Magnani F, Iacobone M, et al
    (18)F-choline PET/CT and PET/MRI in primary and recurrent hyperparathyroidism: a systematic review of the literature.
    Ann Nucl Med. 2020 Aug 7. pii: 10.1007/s12149-020-01507.
    PubMed     Abstract available

  138. MATSUSAKA Y, Nakahara T, Takahashi K, Iwabuchi Y, et al
    Development of (68)Ga-labeled tin colloids for evaluating phagocytic function of Kupffer cells using preclinical PET imaging.
    Ann Nucl Med. 2020 Aug 4. pii: 10.1007/s12149-020-01505.
    PubMed     Abstract available

    July 2020
  139. NOVIKOV SN, Krzhivitskii PI, Kanaev SV, Berlev IV, et al
    SPECT-CT visualization and biopsy of sentinel lymph nodes in patients with stage IAB-IIA cervical cancer.
    Ann Nucl Med. 2020 Jul 15. pii: 10.1007/s12149-020-01503.
    PubMed     Abstract available

  140. MIWA K, Wagatsuma K, Nemoto R, Masubuchi M, et al
    Detection of sub-centimeter lesions using digital TOF-PET/CT system combined with Bayesian penalized likelihood reconstruction algorithm.
    Ann Nucl Med. 2020 Jul 4. pii: 10.1007/s12149-020-01500.
    PubMed     Abstract available

  141. TSUTSUI Y, Awamoto S, Himuro K, Kato T, et al
    Evaluating and comparing the image quality and quantification accuracy of SiPM-PET/CT and PMT-PET/CT.
    Ann Nucl Med. 2020 Jul 3. pii: 10.1007/s12149-020-01496.
    PubMed     Abstract available

    June 2020
  142. CHEN LC, Hung HF, Jong BH, Lin SC, et al
    A method to measure the extent of myocardial ischemia and steal with SPECT myocardial blood flow quantitation.
    Ann Nucl Med. 2020 Jun 30. pii: 10.1007/s12149-020-01493.
    PubMed     Abstract available

  143. TUNCEL M, Kilickap S, Suslu N
    Clinical impact of (68)Ga-DOTATATE PET-CT imaging in patients with medullary thyroid cancer.
    Ann Nucl Med. 2020 Jun 29. pii: 10.1007/s12149-020-01494.
    PubMed     Abstract available

  144. ZHANG Y, Li B, Wu B, Yu H, et al
    Diagnostic performance of whole-body bone scintigraphy in combination with SPECT/CT for detection of bone metastases.
    Ann Nucl Med. 2020 Jun 24. pii: 10.1007/s12149-020-01488.
    PubMed     Abstract available

  145. KUCHARCZAK F, Suau M, Strauss O, Ben Bouallegue F, et al
    Brain (18)F-FDG PET analysis via interval-valued reconstruction: proof of concept for Alzheimer's disease diagnosis.
    Ann Nucl Med. 2020 Jun 23. pii: 10.1007/s12149-020-01490.
    PubMed     Abstract available

  146. WANG Q, Song D, Ma X, Wu X, et al
    Preclinical PET imaging study of lung cancer with (64)CuCl2.
    Ann Nucl Med. 2020 Jun 21. pii: 10.1007/s12149-020-01491.
    PubMed     Abstract available

  147. KOJIMA I, Takanami K, Ogawa T, Sakamoto M, et al
    High detection sensitivity and reliable morphological correlation of PET with a silicon photomultiplier for primary tongue squamous cell carcinoma.
    Ann Nucl Med. 2020 Jun 20. pii: 10.1007/s12149-020-01489.
    PubMed     Abstract available

  148. SHIMOKAWA N, Akamatsu G, Kadosaki M, Sasaki M, et al
    Feasibility study of a PET-only amyloid quantification method: a comparison with visual interpretation.
    Ann Nucl Med. 2020 Jun 13. pii: 10.1007/s12149-020-01486.
    PubMed     Abstract available

  149. KHAW TH, Raynor WY, Borja AJ, Al-Zaghal A, et al
    Assessing the effects of body weight on subchondral bone formation with quantitative (18)F-sodium fluoride PET.
    Ann Nucl Med. 2020 Jun 10. pii: 10.1007/s12149-020-01482.
    PubMed     Abstract available

  150. BELGE G, Bilgin C, Ozkaya G, Kandemirli SG, et al
    Prognostic value of pretreatment tumor-to-blood standardized uptake ratio (SUR) in rectal cancer.
    Ann Nucl Med. 2020;34:432-440.
    PubMed     Abstract available

  151. ONAL C, Torun N, Oymak E, Guler OC, et al
    Retrospective correlation of (68)ga-psma uptake with clinical parameters in prostate cancer patients undergoing definitive radiotherapy.
    Ann Nucl Med. 2020;34:388-396.
    PubMed     Abstract available

    May 2020
  152. OLDAN JD, Glaubiger SA, Khandani AH, Jewells VL, et al
    Detectable size of melanoma metastases to brain on PET/CT.
    Ann Nucl Med. 2020 May 25. pii: 10.1007/s12149-020-01481.
    PubMed     Abstract available

  153. SOHARA K, Kiriyama T, Mizumura S, Ishiwata A, et al
    Diagnostic utility and characteristics of CT-based attenuation correction in brain perfusion SPECT/CT in predicting the exacerbation of Alzheimer changes from mild cognitive impairment utilizing voxel-based statistical analysis in comparison with Chan
    Ann Nucl Med. 2020 May 24. pii: 10.1007/s12149-020-01477.
    PubMed     Abstract available

  154. CHEN YH, Chen HT, Lee MC, Liu SH, et al
    Preoperative F-18 fluorocholine PET/CT for the detection of hyperfunctioning parathyroid glands in patients with secondary or tertiary hyperparathyroidism: comparison with Tc-99m sestamibi scan and neck ultrasound.
    Ann Nucl Med. 2020 May 20. pii: 10.1007/s12149-020-01479.
    PubMed     Abstract available

  155. SENA Y, Matsumoto S, Silman C, Otsuka K, et al
    Physiological 18F-FDG uptake in the normal adult anal canal: evaluation by PET/CT.
    Ann Nucl Med. 2020 May 19. pii: 10.1007/s12149-020-01480.
    PubMed     Abstract available

  156. SIMSEK DH, Sanli Y, Civan C, Engin MN, et al
    Does bone scintigraphy still have a role in the era of 68 Ga-PSMA PET/CT in prostate cancer?
    Ann Nucl Med. 2020 May 11. pii: 10.1007/s12149-020-01474.
    PubMed     Abstract available

  157. HARA S, Kudo T, Hayashi S, Inaji M, et al
    Improvement in cognitive decline after indirect bypass surgery in adult moyamoya disease: implication of (15)O-gas positron emission tomography.
    Ann Nucl Med. 2020 May 6. pii: 10.1007/s12149-020-01473.
    PubMed     Abstract available

  158. SUGAWARA S, Ishii S, Kojima Y, Ito H, et al
    Feasibility of gamma camera-based GFR measurement using renal depth evaluated by lateral scan of (99m)Tc-DTPA renography.
    Ann Nucl Med. 2020;34:349-357.
    PubMed     Abstract available

  159. THIENTUNYAKIT T, Sethanandha C, Muangpaisan W, Chawalparit O, et al
    Relationships between amyloid levels, glucose metabolism, morphologic changes in the brain and clinical status of patients with Alzheimer's disease.
    Ann Nucl Med. 2020;34:337-348.
    PubMed     Abstract available

  160. HU B, Chen W, Zhang Y, Shi H, et al
    (18)F-FDG maximum standard uptake value predicts PD-L1 expression on tumor cells or tumor-infiltrating immune cells in non-small cell lung cancer.
    Ann Nucl Med. 2020;34:322-328.
    PubMed     Abstract available

    April 2020
  161. KIMURA Y, Watanabe A, Yamada T, Watanabe S, et al
    AI approach of cycle-consistent generative adversarial networks to synthesize PET images to train computer-aided diagnosis algorithm for dementia.
    Ann Nucl Med. 2020 Apr 20. pii: 10.1007/s12149-020-01468.
    PubMed     Abstract available

  162. WANG L, Xiong C, Li M, Zeng X, et al
    Assessment of lung glucose uptake in patients with systemic lupus erythematosus pulmonary arterial hypertension: a quantitative FDG-PET imaging study.
    Ann Nucl Med. 2020 Apr 20. pii: 10.1007/s12149-020-01461.
    PubMed     Abstract available

  163. SAKAMOTO F, Shiraishi S, Ogasawara K, Tsuda N, et al
    A diagnostic strategy for Lewy body disease using DAT-SPECT, MIBG and Combined index.
    Ann Nucl Med. 2020 Apr 16. pii: 10.1007/s12149-020-01464.
    PubMed     Abstract available

  164. SERAJ SM, Raynor WY, Revheim ME, Al-Zaghal A, et al
    Assessing the feasibility of NaF-PET/CT versus FDG-PET/CT to detect abdominal aortic calcification or inflammation in rheumatoid arthritis patients.
    Ann Nucl Med. 2020 Apr 10. pii: 10.1007/s12149-020-01463.
    PubMed     Abstract available

  165. SU W, Ren S, Zhu X, Zhang H, et al
    Standardized thresholds of volume-based PET/CT parameters predicting survival of patients with pancreatic head cancer treated with stereotactic body radiation therapy.
    Ann Nucl Med. 2020 Apr 10. pii: 10.1007/s12149-020-01454.
    PubMed     Abstract available

  166. GOETZ TI, Lang EW, Prante O, Maier A, et al
    Three-dimensional Monte Carlo-based voxel-wise tumor dosimetry in patients with neuroendocrine tumors who underwent (177)Lu-DOTATOC therapy.
    Ann Nucl Med. 2020;34:244-253.
    PubMed     Abstract available

  167. BAEK MS, Cho H, Ryu YH, Lyoo CH, et al
    Customized FreeSurfer-based brain atlas for diffeomorphic anatomical registration through exponentiated lie algebra tool.
    Ann Nucl Med. 2020;34:280-288.
    PubMed     Abstract available

  168. HUANG J, Wu J, Zhao L, Liu W, et al
    Quantitative evaluation of salivary gland scintigraphy in Sjogren's syndrome: comparison of diagnostic efficacy and relationship with pathological features of the salivary glands.
    Ann Nucl Med. 2020;34:289-298.
    PubMed     Abstract available

  169. TAJRA JBM, Calegaro JU, de Paula AP, Bachour D, et al
    Accuracy of Oral (67)Gallium Citrate Scintigraphy in assessment of inflammatory activity of Crohn's disease.
    Ann Nucl Med. 2020;34:263-271.
    PubMed     Abstract available

  170. RICCI M, Chiaravalloti A, Martorana A, Koch G, et al
    The role of epsilon phenotype in brain glucose consumption in Alzheimer's disease.
    Ann Nucl Med. 2020;34:254-262.
    PubMed     Abstract available

    March 2020
  171. ITO K
    Toyama H, Li Y, Hatazawa J, Huang G, Kubota K (eds): PET/CT for inflammatory diseases: basic sciences, typical cases, and review : Singapore: Springer Nature Singapore Pte Ltd., 2020, 233 pages, Hardcover, 169.99 euro.
    Ann Nucl Med. 2020 Mar 28. pii: 10.1007/s12149-020-01459.

  172. MAHENDRA I, Hanaoka H, Yamaguchi A, Amartuvshin T, et al
    Diagnosis of bladder cancer using (18)F-labeled alpha-methyl-phenylalanine tracers in a mouse model.
    Ann Nucl Med. 2020 Mar 6. pii: 10.1007/s12149-020-01452.
    PubMed     Abstract available

  173. MUGIKURA S, Mori N, Kikuchi H, Mori E, et al
    Relationship between decreased cerebral blood flow and amnesia after microsurgery for anterior communicating artery aneurysm.
    Ann Nucl Med. 2020;34:220-227.
    PubMed     Abstract available

  174. ROMANOV V, Isohashi K, Alobthani G, Beshr R, et al
    Evaluation of the total distribution volume of (18)F-FBPA in normal tissues of healthy volunteers by non-compartmental kinetic modeling.
    Ann Nucl Med. 2020;34:155-162.
    PubMed     Abstract available

    February 2020
  175. SHARMA A, Okada DR, Yacoub H, Chrispin J, et al
    Diagnosis of cardiac sarcoidosis: an era of paradigm shift.
    Ann Nucl Med. 2020;34:87-93.
    PubMed     Abstract available

  176. OKADA Y, Kato T, Iwata K, Kimura Y, et al
    Evaluation of PiB visual interpretation with CSF Abeta and longitudinal SUVR in J-ADNI study.
    Ann Nucl Med. 2020;34:108-118.
    PubMed     Abstract available

  177. YAMADA T, Watanabe S, Nagaoka T, Nemoto M, et al
    Automatic delineation algorithm of reference region for amyloid imaging based on kinetics.
    Ann Nucl Med. 2020;34:102-107.
    PubMed     Abstract available

    January 2020
  178. YAMAMOTO Y, Mitsunaga S, Horikawa A, Hino A, et al
    Quantitative bone scan imaging using BSI and BUV: an approach to evaluate ARONJ early.
    Ann Nucl Med. 2020;34:74-79.
    PubMed     Abstract available

  179. SASAKI Y
    Nuclear oncology as seen by me in Japan: a historical review and future perspective.
    Ann Nucl Med. 2020;34:1-12.
    PubMed     Abstract available

  180. LIN YC, Chou FI, Yang BH, Chang CW, et al
    Similar T/N ratio between (18)F-FBPA diagnostic and BPA therapeutic dosages for boron neutron capture therapy in orthotropic tongue cancer model.
    Ann Nucl Med. 2020;34:58-64.
    PubMed     Abstract available

  181. MOHD ROHANI MF, Mat Nawi N, Shamim SE, Wan Sohaimi WF, et al
    Maximum standardized uptake value from quantitative bone single-photon emission computed tomography/computed tomography in differentiating metastatic and degenerative joint disease of the spine in prostate cancer patients.
    Ann Nucl Med. 2020;34:39-48.
    PubMed     Abstract available

  182. FUJIWARA K, Tsuji AB, Sudo H, Sugyo A, et al
    (111)In-labeled anti-cadherin17 antibody D2101 has potential as a noninvasive imaging probe for diagnosing gastric cancer and lymph-node metastasis.
    Ann Nucl Med. 2020;34:13-23.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Nuclear Medicine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.